ArticleAdvances in therapy2017

Comment on "Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate".

Roberto RavasioPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.